We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$9.54M
Cap. Flow
-$73.4K
Cap. Flow %
-0.06%
Top 10 Hldgs %
83.4%
Holding
29
New
2
Increased
1
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
LBRX
LB Pharmaceuticals
LBRX
+$7.63M
2
CELC icon
Celcuity
CELC
+$3.09M
3
INSM icon
Insmed
INSM
+$1.01M

Top Sells

Rank Stock Value
1
OCS icon
Oculis Holding
OCS
+$4.34M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$2.96M
3
LAB icon
Standard BioTools
LAB
+$2.41M
4
REPL icon
Replimune Group
REPL
+$619K
5
INCY icon
Incyte
INCY
+$527K

Sector Composition

Rank Sector Weight
1 Healthcare 96.33%
2 Technology 2.51%
3 Industrials 0%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAB icon
26
Standard BioTools
LAB
$326M
– –
-1,883,179
Closed -$2.41M
REPL icon
27
Replimune Group
REPL
$814M
– –
-63,719
Closed -$619K
RKLB icon
28
Rocket Lab Corp
RKLB
$39.9B
– –
-3,824
Closed -$267K
BSLK
29
DELISTED
Bolt Projects Holdings
BSLK
– –
-40,597
Closed -$32.4K
1
2

Similar funds

TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Nan Fung Group Holdings's Q1 2026 Portfolio in Review

As of Q1 2026, Nan Fung Group Holdings held 29 positions worth $121M, up 8.5% from $112M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Nan Fung Group Holdings's Q1 2026 filing shows 2 new, 1 increased, 4 reduced and 5 closed positions. Its largest new stake was Celcuity: 28,300 shares worth $3.23M. The largest sale was Oculis Holding, an estimated $4.34M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Technology and Industrials.

  • Nan Fung Group Holdings's largest Q1 2026 buy was Celcuity: 28,300 shares worth $3.23M.
  • Nan Fung Group Holdings added most to LB Pharmaceuticals in Q1 2026, an estimated $7.63M increase.
  • Nan Fung Group Holdings's biggest Q1 2026 reduction was Oculis Holding, cutting an estimated $4.34M.
  • Nan Fung Group Holdings fully exited Standard BioTools in Q1 2026, selling an estimated $2.41M.
  • Nan Fung Group Holdings's ten largest holdings make up 83% of its $121M portfolio in Q1 2026.
  • Nan Fung Group Holdings opened 2 new positions and closed 5 in Q1 2026.
  • Nan Fung Group Holdings's portfolio value rose 8.5% quarter-over-quarter to $121M.

Based on Nan Fung Group Holdings's 13F filing for Q1 2026, filed 14 May 2026.